NCT03390504 2026-02-02
THOR
Janssen Research & Development, LLC
Phase 3 Active not recruiting
Janssen Research & Development, LLC
Astellas Pharma Inc
Pierre Fabre Medicament
SCRI Development Innovations, LLC
Merck Sharp & Dohme LLC
Pierre Fabre Medicament
Hoffmann-La Roche
Pierre Fabre Medicament
Pierre Fabre Medicament
UNC Lineberger Comprehensive Cancer Center
SCRI Development Innovations, LLC
SCRI Development Innovations, LLC